147 related articles for article (PubMed ID: 28631020)
1. Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.
Bera G; Das RN; Roy P; Ghosh R; Islam N; Mishra PK; Chatterjee U
Pediatr Surg Int; 2017 Sep; 33(9):961-970. PubMed ID: 28631020
[TBL] [Abstract][Full Text] [Related]
2. High tricellulin expression is associated with better survival in human hepatoblastoma.
Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma.
Park WS; Oh RR; Park JY; Kim PJ; Shin MS; Lee JH; Kim HS; Lee SH; Kim SY; Park YG; An WG; Kim HS; Jang JJ; Yoo NJ; Lee JY
J Pathol; 2001 Apr; 193(4):483-90. PubMed ID: 11276007
[TBL] [Abstract][Full Text] [Related]
4. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
Zhou S; Parham DM; Yung E; Pattengale P; Wang L
Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
[TBL] [Abstract][Full Text] [Related]
5. Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma.
Gupta K; Rane S; Das A; Marwaha RK; Menon P; Rao KL
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e320-8. PubMed ID: 22735888
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin and met deregulation in childhood Hepatoblastomas.
Ranganathan S; Tan X; Monga SP
Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454
[TBL] [Abstract][Full Text] [Related]
7. Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma.
Halász J; Holczbauer A; Páska C; Kovács M; Benyó G; Verebély T; Schaff Z; Kiss A
Hum Pathol; 2006 May; 37(5):555-61. PubMed ID: 16647953
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication.
Chopra A; Iyer VK; Agarwala S; Mathur SR; Aron M; Gupta SD; Verma K
Pediatr Surg Int; 2010 Dec; 26(12):1173-8. PubMed ID: 20803149
[TBL] [Abstract][Full Text] [Related]
9. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
[TBL] [Abstract][Full Text] [Related]
10. High mobility group AT-hook 2 is overexpressed in hepatoblastoma.
Lee CT; Zhang L; Mounajjed T; Wu TT
Hum Pathol; 2013 May; 44(5):802-10. PubMed ID: 23134771
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of beta-catenin in hepatoblastoma and its clinical significance.
Archana B; D'Cruze L; Nazneen S; Thanka J; Scott JX
J Cancer Res Ther; 2022; 18(3):677-680. PubMed ID: 35900540
[TBL] [Abstract][Full Text] [Related]
12. Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma.
Huang WJ; Tsai JH; Jeng YM
J Formos Med Assoc; 2017 Jul; 116(7):549-553. PubMed ID: 28277286
[TBL] [Abstract][Full Text] [Related]
13. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
[TBL] [Abstract][Full Text] [Related]
14. Hepatoblastoma--an attempt of histological subtyping on fine-needle aspiration material.
Barwad A; Gupta N; Gupta K; Rajwanshi A; Marwaha RK; Rao KL; Dey P; Srinivasan R; Nijhawan R
Diagn Cytopathol; 2013 Feb; 41(2):95-101. PubMed ID: 22362636
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.
Ara T; Fukuzawa M; Oue T; Komoto Y; Kusafuka T; Imura K; Okada A
J Pediatr Surg; 1997 Dec; 32(12):1690-4. PubMed ID: 9434000
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
17. FNAC Aided Diagnosis and Categorization of Hepatoblastoma:: A Report of Three Cases.
Bera G; Das RN; Islam N; Roy P; Mishra PK; Datta C; Chaudhuri MK; Chatterjee U
Diagn Cytopathol; 2017 Jan; 45(1):77-82. PubMed ID: 27629393
[TBL] [Abstract][Full Text] [Related]
18. Multifocal hepatic neoplasia in 3 children with APC gene mutation.
Gupta A; Sheridan RM; Towbin A; Geller JI; Tiao G; Bove KE
Am J Surg Pathol; 2013 Jul; 37(7):1058-66. PubMed ID: 23715166
[TBL] [Abstract][Full Text] [Related]
19. SALL4 is a marker of the embryonal subtype of hepatoblastoma.
Gnemmi V; Leteurtre E; Sudour-Bonnange H; Devisme L; Guettier C; Buob D; Leroy X
Histopathology; 2013 Sep; 63(3):425-8. PubMed ID: 23822878
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
